컴퓨터 단층촬영(CT) 시장 규모, 점유율, 동향 분석 리포트 : 기술별(하이엔드 슬라이스, 미드엔드 슬라이스), 최종 용도별(병원, 영상진단센터), 용도별(종양, 신경), 지역별, 부문별 예측(2022-2030년)

Computed Tomography Market Growth & Trends:

The global computed tomography market size is expected to reach USD 7,551.7 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.3% from 2022 to 2030. Increasing burden of chronic disorders, such as cardiovascular diseases and cancer, and high demand for effective imaging tools are the factors driving growth. According to the International Agency for Cancer on Research, in 2020 globally there were about 19,292,789 new cancer cases with 9,958,133 deaths. The same source stated that the prevalence of cancer is predicted to increase to 50,550,287 by 2025. In addition, increasing demand for computed tomography (CT) systems in emergency care departments is expected to be a major driver during the forecast period.

Advanced technology with features such as dose management systems, ability to diagnose tumors through motion (4D), artificial intelligence integration and high-end material differentiation is expected to replace the existing conventional devices. In September 2021, GE Healthcare introduced the Revolution Ascend CT system, the technology combines artificial intelligence (AI) to improve operational efficiency and patient comfort. Increasing number of favorable reimbursement policies by government as well as private entities are also expected to drive the market at a lucrative pace. Growing demand for ambulatory diagnostic centers due to improving affordability and increasing reach of CT scanners to remote regions is expected to aid further growth.

Moreover, the inability of alternative imaging technologies to provide quick reports and at the same time be cost-effective boosts growth. These devices and this technology is also routinely upgraded, which is expected to further increase demand over the forecast period. Since the start of the COVID-19 pandemic, demand for CT scanners gradually increased. Large companies like Siemens Healthineers are known to sell over 200 CT scanners each year. The COVID-19 pandemic has resulted in a significant surge in CT scan equipment demand, with Siemens reporting sales of 80 to 100 units in only 45 days. Furthermore, due to increased demand for chest CT examinations in COVID-19 patients, major manufacturers increased the production capacity of CT system.

Computed Tomography Market Report Highlights:

• The high end slice CT segment held the largest market share in 2021, the increasing demand for advance technology with enhanced imaging quality and the shifting focus on providing quality healthcare services has contributed to this growth

• Based on end use, the hospital segment captured largest revenue share in 2021, large patient pool and high demand for CT scanners as a diagnostic tool during treatment are expected to contribute toward the growth of this segment

• North America dominated the market in 2021, owing to high adoption of advanced technology and presence of a large number of market players are some of the factors that can be attributed to this share

• Asia Pacific is expected to grow at the fastest rate over the forecast period, growing demand for advanced imaging techniques and rising number of diagnostic imaging centers are some of the factors driving regional growth

• Major players in the industry are focusing on launch of advanced technology and features such as artificial intelligence enabled, dual source detector technology based CT scanners

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Technology
  • 1.1.2. Application
  • 1.1.3. End-use
  • 1.1.4. Regional
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Technology outlook
  • 2.2.2. Application outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Computed Tomography Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. Increasing ageing population
    • 3.4.1.2. Increasing prevalence of chronic and non-communicable diseases
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. Risk of radiation exposure
  • 3.4.3. Industry challenges
    • 3.4.3.1. Increasing number of product recalls
• 3.5. Computed tomography Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
  • 3.5.3. Major Deals & Strategic Alliances Analysis
  • 3.5.4. Market Entry Strategies

Chapter 4. Technology Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. High end slice
  • 4.1.2. Mid end slice
  • 4.1.3. Low end slice
  • 4.1.4. Cone beam technology
• 4.2. Product Market Share, 2021 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Computed Tomography Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. High end slice
  • 4.5.2. Mid end slice
  • 4.5.3. Low end slice
  • 4.5.4. Cone beam technology

Chapter 5. Application Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Oncology
  • 5.1.2. Neurology
  • 5.1.3. Cardiology
  • 5.1.4. Vascular
  • 5.1.5. Musculoskeletal
  • 5.1.6. Others
• 5.2. Application Market Share, 2021 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Computed Tomography Market by End-use Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Oncology
  • 5.5.2. Neurology
  • 5.5.3. Cardiology
  • 5.5.4. Vascular
  • 5.5.5. Musculoskeletal
  • 5.5.6. Others

Chapter 6. End-use Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Hospitals
  • 6.1.2. Ambulatory imaging center
  • 6.1.3. Diagnostics imaging center
• 6.2. End-use Market Share, 2021 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Computed Tomography Market by End-use Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Hospitals
  • 6.5.2. Ambulatory imaging center
  • 6.5.3. Diagnostics imaging center

Chapter 7. Computed Tomography Market: Regional Estimates & Trend Analysis

• 7.1. Regional market share analysis, 2021 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Regional Market Share and Leading Players, 2021
  • 7.4.1. North America
  • 7.4.2. Europe
  • 7.4.3. Asia Pacific
  • 7.4.4. Latin America
  • 7.4.5. Middle East and Africa
• 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
  • 7.5.1. North America
  • 7.5.2. Europe
  • 7.5.3. Asia Pacific
  • 7.5.4. Latin America
  • 7.5.5. Middle East and Africa
• 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030
• 7.7. North America
  • 7.7.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
  • 7.7.2. U.S.
    • 7.7.2.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
  • 7.7.3. Canada
    • 7.7.3.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
• 7.8. Europe
  • 7.8.1. U.K.
    • 7.8.1.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
  • 7.8.2. Germany
    • 7.8.2.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
  • 7.8.3. France
    • 7.8.3.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
  • 7.8.4. Italy
    • 7.8.4.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
  • 7.8.5. Spain
    • 7.8.5.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
• 7.9. Asia Pacific
  • 7.9.1. Japan
    • 7.9.1.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
  • 7.9.2. China
    • 7.9.2.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
  • 7.9.3. India
    • 7.9.3.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
  • 7.9.4. Thailand
    • 7.9.4.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
  • 7.9.5. South Korea
    • 7.9.5.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
• 7.10. Latin America
  • 7.10.1. Brazil
    • 7.10.1.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
  • 7.10.2. Mexico
    • 7.10.2.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
  • 7.10.3. Argentina
    • 7.10.3.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
  • 7.10.4. Colombia
    • 7.10.4.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
• 7.11. MEA
  • 7.11.1. South Africa
    • 7.11.1.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
  • 7.11.2. Saudi Arabia
    • 7.11.2.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)
  • 7.11.3. UAE
    • 7.11.3.1. Market estimates and forecast, 2018 - 2030 (Value & Volume)

Chapter 8. Competitive Landscape

• 8.1 Recent Developments & Impact Analysis, By Key Market Participants
• 8.2 Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3 Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2021
  • 8.3.4. CANON MEDICAL SYSTEMS CORPORATION
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. FUJIFILM Corporation
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. GENERAL ELECTRIC COMPANY
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Koning Corporation
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Koninklijke Philips NV
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. NeuroLogica Corp
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Neusoft Corporation
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Siemens Healthcare GmbH
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Shenzhen Anke High-Tech Co
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives